People whose families originate from the Outer Hebrides or north‑west Ireland carry the highest known risk of hemochromatosis – a hereditary condition that makes the body hoard excess iron. Over many years that surplus can become dangerous.
For the first time, researchers have produced a detailed map of hemochromatosis risk – sometimes dubbed the “Celtic curse” – across the United Kingdom and Ireland. While clinicians have long observed higher rates in Scottish and Irish communities, the precise geography was previously uncharted.
Why Iron Overload Matters
The disease usually progresses slowly. Iron can silently accumulate in the liver, heart, joints and other organs for decades before any symptoms surface. Left unchecked, it may lead to liver cirrhosis, liver cancer, arthritis and a host of other problems. Detecting the condition early makes a huge difference; a simple routine of blood donation can lower iron levels and prevent most damage.
Hemochromatosis is driven by inherited changes in DNA, most notably the C282Y variant in people of British and Irish descent.
Scientists at the University of Edinburgh examined genetic data from more than 400,000 volunteers in the UK Biobank and Viking Genes projects. They measured how frequently the C282Y variant appeared in 29 distinct areas across the British Isles and Ireland.
Where the Variant Concentrates
The strongest signal emerged from north‑west Ireland, where roughly one in 54 residents is estimated to carry the risky gene. The Outer Hebrides followed closely, with about one carrier per 62 people, and Northern Ireland showed a prevalence of one in 71.
On the mainland, Scotland exhibited elevated rates, especially around Glasgow and the south‑west, where roughly one in 117 individuals carries the variant – reinforcing the old “Celtic curse” nickname.
Because the genetic load is so high in these pockets, focused screening would likely uncover the largest number of cases.
Diagnosis Gaps and Hidden Cases
Reviewing NHS England records, the team identified over 70,000 diagnosed cases of hemochromatosis. White Irish patients were almost four times more likely to receive a diagnosis than white British patients.
Within the white British group, people living in Liverpool were diagnosed eleven times more often than those in Kent, a pattern that mirrors historic Irish migration to the city in the 19th century.
Overall, English diagnosis rates tend to follow the genetic risk map, but some areas—Birmingham, Cumbria, Northumberland and Durham—reported fewer cases than their gene frequencies would predict. These regions may harbor undetected sufferers who would benefit from expanded testing.
Comparable prevalence data were unavailable for Scotland, Wales and Northern Ireland, so those nations could not be evaluated in this part of the study.
The research was funded by Haemochromatosis‑UK and carried out in partnership with RCSI University of Medicine and Health Sciences. Findings were published in *Nature Communications*.
Calls for Community‑Wide Screening
Professor Jim Flett Wilson, chair of human genetics at Edinburgh, stressed that early detection can avert liver cancer, arthritis and other severe outcomes. “About one in sixty people in the Hebrides and Northern Ireland carries the high‑risk gene, and roughly half of them will develop disease if untreated,” he said. “Simple blood‑letting can keep iron in check, so we need a coordinated screening programme in these hotspots.”
Jonathan Jelley, chief executive of Haemochromatosis UK, added that the C282Y variant poses the greatest threat among iron‑overload genotypes and that the new map should drive targeted awareness, diagnosis and treatment pathways for thousands of patients.
Labour MP Torcuil Crichton, who represents the Western Isles and lives with hemochromatosis, echoed the call for screening. He urged the UK National Screening Committee to pilot a programme in the Western Isles, noting that early identification has already saved him from serious health complications.